| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
45,766,000 |
| Market
Cap: |
889.69(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$6.29 - $44.19 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8 |
| Insider 6 Months : 8 |
| Insider 3/6 Months : 16.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. Co.'s product portfolio are: ENROUTE Transcarotid Neuroprotection System, which is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, which is a self-expanding, self-tapering stent that conforms to patient; ENHANCE Transcarotid Peripheral Access Kit, which is used in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire, which is used for navigating and crossing the target lesion for delivery of interventional devices.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
11,700 |
11,700 |
11,700 |
11,700 |
| Total Buy Value |
$198,783 |
$198,783 |
$198,783 |
$198,783 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
27,257 |
27,257 |
43,770 |
602,067 |
| Total Sell Value |
$483,218 |
$483,218 |
$877,159 |
$28,445,866 |
| Total People Sold |
5 |
5 |
6 |
8 |
| Total Sell Transactions |
6 |
6 |
14 |
58 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Buchanan Lucas W. |
COO/CFO |
• – – |
2021-11-16 |
4 |
AS |
$50.32 |
$503,200 |
D/D |
(10,000) |
179,997 |
|
-17% |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2021-11-16 |
4 |
OE |
$4.73 |
$47,300 |
D/D |
10,000 |
189,997 |
|
- |
|
| Rogers Erica J. |
President and CEO |
• • – |
2021-11-11 |
4 |
AS |
$50.47 |
$915,921 |
D/D |
(18,095) |
129,679 |
|
-26% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2021-11-11 |
4 |
OE |
$1.46 |
$24,377 |
D/D |
15,738 |
142,036 |
|
- |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2021-11-01 |
4 |
AS |
$60.96 |
$292,912 |
D/D |
(4,805) |
70,255 |
|
-47% |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2021-11-01 |
4 |
OE |
$4.73 |
$101,343 |
D/D |
4,805 |
70,287 |
|
- |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2021-10-27 |
4 |
AS |
$59.39 |
$593,886 |
D/D |
(10,000) |
179,997 |
|
-44% |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2021-10-27 |
4 |
OE |
$12.15 |
$121,500 |
D/D |
10,000 |
184,186 |
|
- |
|
| Rogers Erica J. |
President and CEO |
• • – |
2021-10-11 |
4 |
AS |
$55.73 |
$613,014 |
D/D |
(11,000) |
132,036 |
|
-44% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2021-10-11 |
4 |
OE |
$1.60 |
$17,600 |
D/D |
11,000 |
143,036 |
|
- |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2021-10-01 |
4 |
D |
$55.24 |
$146,828 |
D/D |
(2,658) |
179,997 |
|
- |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2021-10-01 |
4 |
AS |
$53.90 |
$340,878 |
D/D |
(6,324) |
70,255 |
|
-42% |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2021-10-01 |
4 |
OE |
$4.73 |
$29,913 |
D/D |
6,324 |
72,806 |
|
- |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2021-09-28 |
4 |
AS |
$54.86 |
$548,645 |
D/D |
(10,000) |
182,655 |
|
-40% |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2021-09-28 |
4 |
OE |
$12.15 |
$121,500 |
D/D |
10,000 |
192,655 |
|
- |
|
| Rogers Erica J. |
President and CEO |
• • – |
2021-09-13 |
4 |
AS |
$57.32 |
$630,565 |
D/D |
(11,000) |
132,036 |
|
-42% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2021-09-13 |
4 |
OE |
$1.60 |
$17,600 |
D/D |
11,000 |
143,036 |
|
- |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2021-09-01 |
4 |
AS |
$58.89 |
$386,956 |
D/D |
(6,481) |
70,255 |
|
-35% |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2021-09-01 |
4 |
OE |
$4.73 |
$30,180 |
D/D |
6,324 |
70,606 |
|
- |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2021-08-27 |
4 |
AS |
$54.38 |
$543,801 |
D/D |
(10,000) |
182,655 |
|
-28% |
|
| Buchanan Lucas W. |
COO/CFO |
• – – |
2021-08-27 |
4 |
OE |
$12.15 |
$71,041 |
D/D |
5,847 |
192,655 |
|
- |
|
| Ruedy Richard |
EVPClin&Reg.Affairs&QA |
• – – |
2021-08-27 |
4 |
AS |
$55.00 |
$847,385 |
D/D |
(15,407) |
117,368 |
|
-28% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2021-08-11 |
4 |
AS |
$49.12 |
$540,318 |
D/D |
(11,000) |
132,036 |
|
-13% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2021-08-11 |
4 |
OE |
$1.60 |
$17,600 |
D/D |
11,000 |
143,036 |
|
- |
|
| Davis Andrew S. |
Chief Commercial Officer |
• – – |
2021-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
38,820 |
70,412 |
|
- |
|
169 Records found
|
|
Page 5 of 7 |
|
|
0.54 (2.86%) 
